{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37748505", "DateCompleted": {"Year": "2023", "Month": "11", "Day": "30"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "09", "Day": "25"}], "Language": ["eng"], "ELocationID": ["10.1055/a-2173-8627"], "Journal": {"ISSN": "1439-0221", "JournalIssue": {"Volume": "89", "Issue": "15", "PubDate": {"Year": "2023", "Month": "Dec"}}, "Title": "Planta medica", "ISOAbbreviation": "Planta Med"}, "ArticleTitle": "Exploring Immune Modulatory Effects of Cyclotide-Enriched Viola tricolor Preparations.", "Pagination": {"StartPage": "1493", "EndPage": "1504", "MedlinePgn": "1493-1504"}, "Abstract": {"AbstractText": ["<i>Viola tricolor</i> is a medicinal plant with documented application as an anti-inflammatory herb. The standard of care for the treatment of inflammatory bowel disease is immunosuppressive therapeutics or biologics, which often have undesired effects. We explored <i>V.\u00a0tricolor</i> herbal preparations that are rich in an emerging class of phytochemicals with drug-like properties, so-called cyclotides. As an alternative to existing inflammatory bowel disease medications, cyclotides have immunomodulatory properties, and their intrinsic stability allows for application in the gastrointestinal tract, for instance, via oral administration. We optimized the isolation procedure to improve the yield of cyclotides and compared the cellular effects of violet-derived organic solvent-extracts, aqueous preparations, and an isolated cyclotide from this plant on primary human T lymphocytes and macrophages, i.e., cells that are crucial for the initiation and progression of inflammatory bowel disease. The hot water herbal decoctions have a stronger immunosuppressive activity towards proliferation, interferon-<i>\u03b3</i>, and interleukin-21 secretion of primary human T cells than a DCM/MeOH cyclotide-enriched extract, and the isolated cyclotide kalata S appears as one of the active components responsible for the observed effects. This effect was increased by a longer boiling duration. In contrast, the DCM/MeOH cyclotide-enriched extract was more effective in reducing the levels of cytokines interleukin-6, interleukin-12, interleukin-23, tumor necrosis factor-<i>\u03b1</i>, and C\u200a-\u200aX-C motif chemokine ligand 10, secreted by human monocyte-derived macrophages. Defined cyclotide preparations of <i>V.\u00a0tricolor</i> have promising pharmacological effects in modulating immune cell responses at the cytokine levels. This is important towards understanding the role of cyclotide-containing herbal drug preparations for future applications in immune disorders, such as inflammatory bowel disease."], "CopyrightInformation": "The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Physiology and Pharmacology, Medical University of Vienna, Austria."}], "LastName": "Retzl", "ForeName": "Bernhard", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Translational Complementary Medicine, Department of Pharmaceutical Sciences, University of Basel, Switzerland."}], "LastName": "Zimmermann-Klemd", "ForeName": "Amy Marisa", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Translational Complementary Medicine, Department of Pharmaceutical Sciences, University of Basel, Switzerland."}], "LastName": "Winker", "ForeName": "Moritz", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Translational Complementary Medicine, Department of Pharmaceutical Sciences, University of Basel, Switzerland."}], "LastName": "Nicolay", "ForeName": "Sven", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Translational Complementary Medicine, Department of Pharmaceutical Sciences, University of Basel, Switzerland."}], "LastName": "Gr\u00fcndemann", "ForeName": "Carsten", "Initials": "C"}, {"Identifier": ["0000-0001-6060-7048"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Physiology and Pharmacology, Medical University of Vienna, Austria."}], "LastName": "Gruber", "ForeName": "Christian W", "Initials": "CW"}], "GrantList": [{"GrantID": "Natvantage Grant 2019", "Agency": "Wilhelm D\u00f6renkamp Stiftung", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Planta Med", "NlmUniqueID": "0066751", "ISSNLinking": "0032-0943"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cyclotides"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Cyclotides"}, {"QualifierName": ["chemistry"], "DescriptorName": "Viola"}, {"QualifierName": [], "DescriptorName": "T-Lymphocytes"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pharmacology", "chemistry"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Inflammatory Bowel Diseases"}], "CoiStatement": "The authors declare that they have no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Conzelmann C, Muratspahic E, Tomasevic N, Munch J, Gruber C W. In vitro Inhibition of HIV-1 by Cyclotide-Enriched Extracts of Viola tricolor. Front Pharmacol. 2022;13:888961.", "ArticleIdList": ["PMC9196940", "35712712"]}, {"Citation": "Lim T K. Dordrecht: Springer; 2014. Edible Medicinal and non Medicinal Plants, vol. 8."}, {"Citation": "Rimkiene S, Ragazinskiene O, Savickiene N. The cumulation of wild pansy ( Viola tricolor L.) accessions: the possibility of species preservation and usage in medicine . Medicina (Kaunas) 2003;39:411\u2013416.", "ArticleIdList": ["12738912"]}, {"Citation": "Hellinger R, Koehbach J, Soltis D E, Carpenter E J, Wong G K, Gruber C W. Peptidomics of circular cysteine-rich plant peptides: Analysis of the diversity of cyclotides from Viola tricolor by transcriptome and proteome mining . J Proteome Res. 2015;14:4851\u20134862.", "ArticleIdList": ["PMC4642221", "26399495"]}, {"Citation": "de Veer S J, Kan M W, Craik D J. Cyclotides: From structure to function. Chem Rev. 2019;119:12375\u201312421.", "ArticleIdList": ["31829013"]}, {"Citation": "Colgrave M L, Craik D J. Thermal, chemical, and enzymatic stability of the cyclotide kalata B1:\u2009The Importance of the cyclic cystine knot. Biochemistry. 2004;43:5965\u20135975.", "ArticleIdList": ["15147180"]}, {"Citation": "Grundemann C, Koehbach J, Huber R, Gruber C W. Do plant cyclotides have potential as immunosuppressant peptides? J Nat Prod. 2012;75:167\u2013174.", "ArticleIdList": ["PMC3399773", "22272797"]}, {"Citation": "Grundemann C, Thell K, Lengen K, Garcia-Kaufer M, Huang Y H, Huber R, Craik D J, Schabbauer G, Gruber C W. Cyclotides suppress human T-lymphocyte proliferation by an interleukin 2-dependent mechanism. PLoS One. 2013;8:e68016.", "ArticleIdList": ["PMC3694003", "23840803"]}, {"Citation": "Falanga C M, Steinborn C, Muratspahic E, Zimmermann-Klemd A M, Winker M, Krenn L, Huber R, Gruber C W, Grundemann C. Ipecac root extracts and isolated circular peptides differentially suppress inflammatory immune response characterised by proliferation, activation and degranulation capacity of human lymphocytes in vitro. Biomed Pharmacother. 2022;152:113120.", "ArticleIdList": ["PMC7614192", "35653889"]}, {"Citation": "Thell K, Hellinger R, Sahin E, Michenthaler P, Gold-Binder M, Haider T, Kuttke M, Liutkeviciute Z, Goransson U, Grundemann C, Schabbauer G, Gruber C W. Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis. Proc Natl Acad Sci U S A. 2016;113:3960\u20133965.", "ArticleIdList": ["PMC4839460", "27035952"]}, {"Citation": "Gr\u00fcndemann C, Stenberg K G, Gruber C W. T20K: An immunomodulatory cyclotide on its way to the clinic. Int J Pept Res Ther. 2018;25:9\u201313."}, {"Citation": "Hellinger R, Muratspahic E, Devi S, Koehbach J, Vasileva M, Harvey P J, Craik D J, Grundemann C, Gruber C W. Importance of the cyclic cystine knot structural motif for immunosuppressive effects of cyclotides. ACS Chem Biol. 2021;16:2373\u20132386.", "ArticleIdList": ["PMC9286316", "34592097"]}, {"Citation": "Hellinger R, Koehbach J, Fedchuk H, Sauer B, Huber R, Gruber C W, Grundemann C. Immunosuppressive activity of an aqueous Viola tricolor herbal extract . J Ethnopharmacol. 2014;151:299\u2013306.", "ArticleIdList": ["PMC3918579", "24216163"]}, {"Citation": "Imam T, Park S, Kaplan M H, Olson M R. Effector T helper cell subsets in inflammatory bowel diseases. Front Immunol. 2018;9:1212.", "ArticleIdList": ["PMC5992276", "29910812"]}, {"Citation": "Han X, Ding S, Jiang H, Liu G. Roles of macrophages in the development and treatment of gut inflammation. Front Cell Dev Biol. 2021;9:625423.", "ArticleIdList": ["PMC7960654", "33738283"]}, {"Citation": "Neurath M F. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014;14:329\u2013342.", "ArticleIdList": ["24751956"]}, {"Citation": "Giuffrida P, Di Sabatino A. Targeting T cells in inflammatory bowel disease. Pharmacol Res. 2020;159:105040.", "ArticleIdList": ["32585338"]}, {"Citation": "Deutsches \u00c4rzteblatt  Autoimmunerkrankungen haben in Deutschland\u00a0zugenommenAccessed November 10, 2022 at:https://www.aerzteblatt.de/nachrichten/123654/Autoimmunerkrankungen-haben-in-Deutschland-zugenommen"}, {"Citation": "Allison A C. Immunosuppressive drugs: The first 50 years and a glance forward. Immunopharmacology. 2000;47:63\u201383.", "ArticleIdList": ["10878284"]}, {"Citation": "Aslam B, Wang W, Arshad M I, Khurshid M, Muzammil S, Rasool M H, Nisar M A, Alvi R F, Aslam M A, Qamar M U, Salamat M KF, Baloch Z. Antibiotic resistance: A rundown of a global crisis. Infect Drug Resist. 2018;11:1645\u20131658.", "ArticleIdList": ["PMC6188119", "30349322"]}, {"Citation": "Daubert C, Behar N, Martins R P, Mabo P, Leclercq C. Avoiding non-responders to cardiac resynchronization therapy: A practical guide. Eur Heart J. 2017;38:1463\u20131472.", "ArticleIdList": ["27371720"]}, {"Citation": "Mathur S, Hoskins C. Drug development: Lessons from nature. Biomed Rep. 2017;6:612\u2013614.", "ArticleIdList": ["PMC5449954", "28584631"]}, {"Citation": "R\u00edo J, Comabella M, Montalban X. Predicting responders to therapies for multiple sclerosis. Nat Rev Neurol. 2009;5:553\u2013560.", "ArticleIdList": ["19794514"]}, {"Citation": "Statista  Prevalence of diagnosed autoimmune conditions in selected countries 2019Accessed November 10, 2022 at:https://www.statista.com/statistics/418328/diagnosed-autoimmune-conditions-prevalence-in-selected-countries/"}, {"Citation": "Khan U, Ghazanfar H. T Lymphocytes and autoimmunity. Int Rev Cell Mol Biol. 2018;341:125\u2013168.", "ArticleIdList": ["30262031"]}, {"Citation": "Holm T L, Tornehave D, S\u00f8ndergaard H, Kvist P H, Sondergaard B C, Hansen L, Hermit M B, Holgersen K, Vergo S, Frederiksen K S, Haase C, Lundsgaard D. Evaluating IL-21 as a potential therapeutic target in Crohn\u02bcs disease. Gastroenterol Res Pract. 2018;2018:5.962624E6.", "ArticleIdList": ["PMC5914125", "29849593"]}, {"Citation": "Butterweck V, Nahrstedt A. What is the best strategy for preclinical testing of botanicals? A critical perspective. Planta Med. 2012;78:747\u2013754.", "ArticleIdList": ["22499562"]}, {"Citation": "Monteleone G, Monteleone I, Fina D, Vavassori P, Del Vecchio Blanco G, Caruso R, Tersigni R, Alessandroni L, Biancone L, Naccari G C, MacDonald T T, Pallone F. Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn\u02bcs disease. Gastroenterology. 2005;128:687\u2013694.", "ArticleIdList": ["15765404"]}, {"Citation": "Spolski R, Leonard W J. Interleukin-21: A double-edged sword with therapeutic potential. Nat Rev Drug Discov. 2014;13:379\u2013395.", "ArticleIdList": ["24751819"]}, {"Citation": "Schmitt H, Neurath M F, Atreya R. Role of the IL23/IL17 pathway in crohn\u02bcs disease. Front Immunol. 2021;12:622934.", "ArticleIdList": ["PMC8042267", "33859636"]}, {"Citation": "Kashani A, Schwartz D A. The expanding role of anti-IL-12 and/or anti-IL-23 antibodies in the treatment of inflammatory bowel disease. Gastroenterol Hepatol. 2019;15:255\u2013265.", "ArticleIdList": ["PMC6589846", "31360139"]}, {"Citation": "Thierfelder W E, van Deursen J M, Yamamoto K, Tripp R A, Sarawar S R, Carson R T, Sangster M Y, Vignali D A, Doherty P C, Grosveld G C, Ihle J N. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature. 1996;382:171\u2013174.", "ArticleIdList": ["8700208"]}, {"Citation": "Vignali D A, Kuchroo V K. IL-12 family cytokines: Immunological playmakers. Nat Immunol. 2012;13:722\u2013728.", "ArticleIdList": ["PMC4158817", "22814351"]}, {"Citation": "Gaffen S L, Jain R, Garg A V, Cua D J. The IL-23-IL-17 immune axis: From mechanisms to therapeutic testing. Nat Rev Immunol. 2014;14:585\u2013600.", "ArticleIdList": ["PMC4281037", "25145755"]}, {"Citation": "Frieder J, Kivelevitch D, Haugh I, Watson I, Menter A. Anti-IL-23 and anti-IL-17 biologic agents for the treatment of immune-mediated inflammatory conditions. Clin Pharmacol Ther. 2018;103:88\u2013101.", "ArticleIdList": ["28960267"]}, {"Citation": "Mayer L, Sandborn W J, Stepanov Y, Geboes K, Hardi R, Yellin M, Tao X, Xu L A, Salter-Cid L, Gujrathi S, Aranda R, Luo A Y. Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: A phase II randomised study. Gut. 2014;63:442\u2013450.", "ArticleIdList": ["PMC3933070", "23461895"]}, {"Citation": "Zhao Q, Kim T, Pang J, Sun W, Yang X, Wang J, Song Y, Zhang H, Sun H, Rangan V, Deshpande S, Tang H, Cvijic M E, Westhouse R, Olah T, Xie J, Struthers M, Salter-Cid L. A novel function of CXCL10 in mediating monocyte production of proinflammatory cytokines. J Leukoc Biol. 2017;102:1271\u20131280.", "ArticleIdList": ["28899907"]}, {"Citation": "Springer T A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301\u2013314.", "ArticleIdList": ["7507411"]}, {"Citation": "C\u00f4t\u00e9-Daigneault J, Bouin M, Lahaie R, Colombel J F, Poitras P. Biologics in inflammatory bowel disease: What are the data? United European Gastroenterol J. 2015;3:419\u2013428.", "ArticleIdList": ["PMC4625751", "26535119"]}, {"Citation": "Hopkins A L. Network pharmacology: The next paradigm in drug discovery. Nat Chem Biol. 2008;4:682\u2013690.", "ArticleIdList": ["18936753"]}, {"Citation": "Y\u0131ld\u0131r\u0131m M A, Goh K I, Cusick M E, Barab\u00e1si A L, Vidal M. Drug-target network. Nat Biotechnol. 2007;25:1119\u20131126.", "ArticleIdList": ["17921997"]}, {"Citation": "Talevi A. Multi-target pharmacology: Possibilities and limitations of the \u201cskeleton key approach\u201d from a medicinal chemist perspective. Front Pharmacol. 2015;6:205.", "ArticleIdList": ["PMC4585027", "26441661"]}, {"Citation": "Morphy R, Rankovic Z. Designed multiple ligands. An emerging drug discovery paradigm. J Med Chem. 2005;48:6523\u20136543.", "ArticleIdList": ["16220969"]}, {"Citation": "Koeberle A, Werz O. Multi-target approach for natural products in inflammation. Drug Discov Today. 2014;19:1871\u20131882.", "ArticleIdList": ["25172801"]}, {"Citation": "Niedermeyer T H, Strohalm M. mMass as a software tool for the annotation of cyclic peptide tandem mass spectra. PLoS One. 2012;7:e44913.", "ArticleIdList": ["PMC3441486", "23028676"]}, {"Citation": "Sturm M, Kohlbacher O. TOPPView: An open-source viewer for mass spectrometry data. J Proteome Res. 2009;8:3760\u20133763.", "ArticleIdList": ["19425593"]}, {"Citation": "Gattringer J, Ndogo O E, Retzl B, Ebermann C, Gruber C W, Hellinger R. Cyclotides isolated from violet plants of Cameroon are inhibitors of human prolyl oligopeptidase. Front Pharmacol. 2021;12:707596.", "ArticleIdList": ["PMC8311463", "34322026"]}, {"Citation": "Parish I A, Rao S, Smyth G K, Juelich T, Denyer G S, Davey G M, Strasser A, Heath W R. The molecular signature of CD8+ T cells undergoing deletional tolerance. Blood. 2009;113:4575\u20134585.", "ArticleIdList": ["PMC2680364", "19204323"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "11", "Day": "30", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "9", "Day": "26", "Hour": "0", "Minute": "42"}, {"Year": "2023", "Month": "9", "Day": "25", "Hour": "18", "Minute": "53"}, {"Year": "2023", "Month": "9", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37748505", "PMC10684336", "10.1055/a-2173-8627"]}}], "PubmedBookArticle": []}